Section 1 of 6
Terms and abbreviations
1 evidence topic · 0 sources
| Abbreviation | Term |
|---|---|
| ADL | Activities of daily living |
| AHFS | American Hospital Formulary Service |
| CGI-S | Clinical Global Impression of Severity |
| CI | Confidence interval |
| CTC | Cerebello-thalamo-cortical |
| DBS | Deep brain stimulation |
| ET | Essential tremor |
| FDA | Food and Drug Administration |
| HCC | Healthcare costs |
| HCl | Hydrochloride |
| IDMC | Independent Data Monitoring Committee |
| ITT | Intention-to-treat |
| mADL | Modified activities of daily living |
| mADL11 | Modified activities of daily living scale comprising 11 items |
| MDC | Minimum detectable change |
| MDS | International Parkinson and Movement Disorder Society |
| mITT | Modified intention-to-treat |
| MMRM | Mixed model for repeated measures |
| MRI | Magnetic resonance imaging |
| MSD | Meaningful score difference |
| NDA | New Drug Application |
| NREM | Non-rapid eye movement |
| OR | Odds ratio |
| PD | Pharmacodynamics |
| PDUFA | Prescription Drug User Fee Act |
| PGI-C | Patient Global Impression of Change |
| PK | Pharmacokinetics |
| PPPY | Per patient per year |
| QD | Once daily |
| RW | Randomized withdrawal |
| SD | Standard deviation |
| TEAE | Treatment-emergent adverse event |
| TETRAS | The Essential Tremor Rating Assessment Scale |
| TETRAS-ADL | TETRAS Activities of Daily Living subscale |
| TETRAS-PRO | TETRAS patient-reported outcome measure |
| TETRAS-UL | TETRAS upper limb score |
| US | United States |